Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

Datoo MS., Natama MH., Somé A., Traoré O., Rouamba T., Bellamy D., Yameogo P., Valia D., Tegneri M., Ouedraogo F., Soma R., Sawadogo S., Sorgho F., Derra K., Rouamba E., Orindi B., Ramos Lopez F., Flaxman A., Cappuccini F., Kailath R., Elias S., Mukhopadhyay E., Noe A., Cairns M., Lawrie A., Roberts R., Valéa I., Sorgho H., Williams N., Glenn G., Fries L., Reimer J., Ewer KJ., Shaligram U., Hill AVS., Tinto H.

DOI

10.1016/s0140-6736(21)00943-0

Type

Journal article

Journal

The Lancet

Publisher

Elsevier BV

Publication Date

05/2021

Volume

397

Pages

1809 - 1818

Permalink Original publication